Hide

FocusBar

Subscribe to Premium Member
Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M73,353Revenue $M123,098Net Margin (%)3.1Z-Score4.4
Enterprise Value $M81,461EPS $3.2Operating Margin %5.9F-Score7
P/E(ttm))18.5Cash Flow Per Share $4.1Pre-tax Margin (%)5.1Higher ROA y-yY
Price/Book2.010-y EBITDA Growth Rate %19.9Quick Ratio0.7Cash flow > EarningsY
Price/Sales0.65-y EBITDA Growth Rate %8.0Current Ratio1.4Lower Leverage y-yN
Price/Cash Flow11.4y-y EBITDA Growth Rate %22.5ROA % (ttm)5.9Higher Current Ratio y-yY
Dividend Yield %1.3Insider Buy (3m)0ROE % (ttm)10.3Less Shares Outstanding y-yN
Payout Ratio %22.2Shares Outstanding M1,231ROI % (ttm)8.8Gross Margin Increase y-yY

Gurus Latest Trades with CVS

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL
Number of guru portfolios checked: 51.

No Entry found!

CVS is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
CVS Vanguard Health Care Fund 2013-03-311,699,8000.140.37+466.6%
CVS Mario Gabelli 2013-03-311,633,6620.130.57+3.13%
CVS Scott Black 2013-03-31173,5330.011.2+0.5%
CVS PRIMECAP Management 2013-03-3121,00000
CVS Ruane Cunniff 2013-03-3126,15500.01-0.38%
CVS James Barrow 2013-03-31686,8950.060.07-27%
CVS Joel Greenblatt 2013-03-3160,14400.17-30.68%
CVS Wallace Weitz 2013-03-31557,7000.051.2-32.31%
CVS Ray Dalio 2013-03-31340,4500.030.17-44.46%
CVS John Hussman 2013-03-31000Sold Out
Premium Most recent portfolio changes are included for Premium Members only!


CVS: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Finucane Anne A.Director 2013-04-15Sell500$57.244.66view
Brennan Troyen AEVP, Chief Medical Officer 2013-04-15Sell139,618$57.314.54view
Brennan Troyen AEVP, Chief Medical Officer 2013-03-19Sell34,422$5410.94view
PICCOLO C ADirector 2012-12-14Sell98,555$49.1721.84view
Sussman AndrewSVP & President, MinuteClinic 2012-10-04Sell9,020$4922.27view
Bisaccia LisaSVP, Chief HR Officer 2012-10-01Sell56,493$48.4223.73view
Moriarty Thomas MEVP & General Counsel 2012-10-01Buy6,164$48.6723.09view
Joyner J. DavidEVP, Sales & Account Services 2012-09-19Sell33,903$4824.81view
Finucane Anne A.Director 2012-09-17Sell1,000$46.8727.82view
Denton David MEVP, CFO 2012-09-13Sell11,526$4727.47view

Press Releases about CVS :

Quarterly/Annual Reports about CVS:

News about CVS:

Articles On GuruFocus.com
Walgreen Co. (WAG) Dividend Stock Analysis Apr 05 2013 
Chris Davis' Davis New York Venure Fund 2013 Annual Commentary Mar 08 2013 
Early Movers for Feb. 6, 2013 Feb 06 2013 
Delphi Management's Scott Black Releases Fourth Quarter New Stocks Jan 31 2013 
Dividend Contenders in Value for the Accumulation or Income Distribution Phase of the Retirement Por Jan 30 2013 
Steven Romick’s Top Growth Predictable Stocks Jan 22 2013 
My 4 Favorites from the 20 Most Recommended Dividend Stocks at All-Time Highs Jan 19 2013 
Why Is Leon Cooperman Shopping in Walgreen’s? Dec 16 2012 
CVS Caremark Corp: Fundamental Stock Research Analysis Dec 03 2012 
comment on CVS Nov 19 2012 

More From Our Partners
Rite Aid Continues Debt Refinancing - Analyst Blog Jun 18 2013 - ZACKS

Add Notes, Comments or Ask Questions

Comments

No comment yet
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK